NNovo Nordisk Read More Novo Nordisk’s Profit Surge Masks the Real Story: A Pipeline Pivot Underway2026-05-07 Novo Nordisk beats Q1 earnings estimates, scraps CagriSema combo therapy, raises 2026 guidance, and bets on oral GLP-1…